 |
인쇄하기
취소
|
Sales of weight loss pill likely to be prohibited in Korea
The controversial anti-obesity drug sibutramine could be banned in India, according to pharmaceutical sources.
The Korea Food and Drug Administration (KFDA) is coming under criticism for its lax management of controversial sibutramine-based drugs used for weight loss, which have recently been banned from the U.S. and European markets.
The KFDA, which reapproved its safety and distribution...
The Korea Food and Drug Administration (KFDA) is coming under criticism for its lax management of controversial sibutramine-based drugs used for weight loss, which have recently been banned from the U.S. and European markets.
The KFDA, which reapproved its safety and distribution...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.